These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6595181)
1. Structure-activity studies on synthetic analogues (indolactams) of the tumor promoter teleocidin. Fujiki H; Suganuma M; Nakayasu M; Tahira T; Endo Y; Shudo K; Sugimura T Gan; 1984 Oct; 75(10):866-70. PubMed ID: 6595181 [TBL] [Abstract][Full Text] [Related]
2. Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promoters. Hirota M; Suganuma M; Yoshizawa S; Horiuchi T; Nakayasu M; Hasegawa M; Endo Y; Shudo K; Fujiki H Jpn J Cancer Res; 1987 Jun; 78(6):577-82. PubMed ID: 3112073 [TBL] [Abstract][Full Text] [Related]
3. Studies on olivoretins indicate a requirement for a free hydroxyl group for teleocidin B activity. Horiuchi T; Fujiki H; Suganuma M; Hakii H; Nakayasu M; Hitotsuyanagi Y; Aimi N; Sakai S; Endo Y; Shudo K Gan; 1984 Oct; 75(10):837-40. PubMed ID: 6439591 [TBL] [Abstract][Full Text] [Related]
4. Pendolmycin, a new tumor promoter of the teleocidin A class on skin of CD-1 mice. Nishiwaki S; Fujiki H; Yoshizawa S; Suganuma M; Furuya-Suguri H; Okabe S; Nakayasu M; Okabe K; Muratake H; Natsume M Jpn J Cancer Res; 1991 Jul; 82(7):779-83. PubMed ID: 1908844 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies of the indole alkaloid tumor promoter teleocidins. Irie K; Hagiwara N; Tokuda H; Koshimizu K Carcinogenesis; 1987 Apr; 8(4):547-52. PubMed ID: 3103947 [TBL] [Abstract][Full Text] [Related]
7. A possible naturally occurring tumor promoter, teleocidin B from Streptomyces. Fujiki H; Mori M; Nakayasu M; Terada M; Sugimura T Biochem Biophys Res Commun; 1979 Oct; 90(3):976-83. PubMed ID: 292437 [No Abstract] [Full Text] [Related]
8. Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-benzolactam-V8-310. Okabe S; Sueoka N; Komori A; Suganuma M; Endo Y; Shudo K; Fujiki H Biol Pharm Bull; 1998 May; 21(5):465-8. PubMed ID: 9635501 [TBL] [Abstract][Full Text] [Related]
9. Estimation of tumor promoting activity and structure-function relationships of aplysiatoxins. Suganuma M; Fujiki H; Tahira T; Cheuk C; Moore RE; Sugimura T Carcinogenesis; 1984 Mar; 5(3):315-8. PubMed ID: 6323046 [TBL] [Abstract][Full Text] [Related]
10. Nakahara memorial lecture. New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin. Fujiki H; Suganuma M; Tahira T; Yoshioka A; Nakayasu M; Endo Y; Shudo K; Takayama S; Moore RE; Sugimura T Princess Takamatsu Symp; 1983; 14():37-45. PubMed ID: 6151565 [TBL] [Abstract][Full Text] [Related]
11. Effects of synthetic analogues of teleocidin, indolactam-V, on the differentiation of murine pre-adipose cells. Sato M; Hiragun A; Shudo K Cancer Lett; 1985 Jan; 25(3):261-9. PubMed ID: 3918784 [TBL] [Abstract][Full Text] [Related]
12. Similarity of teleocidin B and phorbol ester tumour promoters in effects on membrane receptors. Umezawa K; Weinstein IB; Horowitz A; Fujiki H; Matsushima T; Sugimura T Nature; 1981 Apr; 290(5805):411-3. PubMed ID: 6261139 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activities of (-)-6-n-octyl-indolactam-V, a new potent analogue of the tumor promoter (-)-indolactam-V. Nakagawa Y; Irie K; Nakamura Y; Ohigashi H; Hayashi H Biosci Biotechnol Biochem; 1998 Aug; 62(8):1568-73. PubMed ID: 9757563 [TBL] [Abstract][Full Text] [Related]
14. Absence of synergistic effects on tumor promotion in CD-1 mouse skin by simultaneous applications of two different types of tumor promoters, okadaic acid and teleocidin. Suganuma M; Yatsunami J; Yoshizawa S; Okabe S; Fujiki H Cancer Res; 1993 Mar; 53(5):1012-6. PubMed ID: 8439947 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship in the induction of Epstein-Barr virus by teleocidin derivatives. Irie K; Tokuda H; Hagiwara N; Koshimizu K; Hayashi H; Murao S; Ito Y Int J Cancer; 1985 Oct; 36(4):485-8. PubMed ID: 2995261 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolism. Horowitz AD; Fujiki H; Weinstein IB; Jeffrey A; Okin E; Moore RE; Sugimura T Cancer Res; 1983 Apr; 43(4):1529-35. PubMed ID: 6299522 [TBL] [Abstract][Full Text] [Related]
17. Structure-activity studies of aplysiatoxin-type tumor promoters. Moore RE Princess Takamatsu Symp; 1983; 14():49-57. PubMed ID: 6243065 [TBL] [Abstract][Full Text] [Related]
18. Biological activities and cellular uptake studies of fluorescent derivatives of indole alkaloid tumor promoter teleocidin. Irie K; Okuno S; Koshimizu K; Tokuda H; Nishino H; Iwashima A Int J Cancer; 1989 Mar; 43(3):513-9. PubMed ID: 2538401 [TBL] [Abstract][Full Text] [Related]
19. Specific binding, stimulation of rodent urinary bladder epithelial ornithine decarboxylase, and induction of transitional cell hyperplasia by the skin tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Verma AK; Ertürk E; Bryan GT Cancer Res; 1983 Dec; 43(12 Pt 1):5964-71. PubMed ID: 6315223 [TBL] [Abstract][Full Text] [Related]
20. Modulation of phorbol ester receptors in mouse skin by application of quercetin. Horiuchi T; Fujiki H; Hakii H; Suganuma M; Yamashita K; Sugimura T Jpn J Cancer Res; 1986 Jun; 77(6):526-31. PubMed ID: 3089985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]